PAGNIN, ELISA
 Distribuzione geografica
Continente #
NA - Nord America 4.802
EU - Europa 562
AS - Asia 473
OC - Oceania 3
SA - Sud America 2
Totale 5.842
Nazione #
US - Stati Uniti d'America 4.801
CN - Cina 287
SG - Singapore 137
IT - Italia 104
DE - Germania 93
FI - Finlandia 92
SE - Svezia 78
UA - Ucraina 58
GB - Regno Unito 50
FR - Francia 39
VN - Vietnam 34
NL - Olanda 13
IN - India 10
IE - Irlanda 8
SI - Slovenia 8
CH - Svizzera 6
ES - Italia 4
GR - Grecia 3
RU - Federazione Russa 3
AU - Australia 2
BG - Bulgaria 2
BR - Brasile 2
JP - Giappone 2
TR - Turchia 2
BE - Belgio 1
CA - Canada 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
Totale 5.842
Città #
Fairfield 879
Houston 476
Chandler 428
Woodbridge 411
Ashburn 343
Seattle 332
Wilmington 312
Cambridge 310
Jacksonville 259
Ann Arbor 197
Princeton 115
Singapore 96
San Diego 70
Beijing 58
Roxbury 57
Nanjing 52
Boardman 40
Helsinki 39
Dong Ket 34
Medford 34
Guangzhou 28
Des Moines 27
New York 24
Padova 21
Nanchang 17
Santa Clara 17
Jinan 12
Dublin 8
Jiaxing 8
Norwalk 8
Hefei 7
London 7
Shenyang 7
Taizhou 7
Changsha 6
Dallas 6
Frankfurt am Main 6
Ogden 6
Shanghai 6
Hebei 5
Kharkiv 5
Kilburn 5
Kunming 5
Redwood City 5
Tappahannock 5
Tianjin 5
Zhengzhou 5
Borås 4
Chiswick 4
Fuzhou 4
Los Angeles 4
Detroit 3
Falls Church 3
Hangzhou 3
Indiana 3
Madrid 3
Milan 3
Munich 3
Nürnberg 3
Palermo 3
Phoenix 3
Southwark 3
Washington 3
Zurich 3
Acton 2
Amsterdam 2
Atlanta 2
Auburn Hills 2
Baotou 2
Castelbuono 2
Castelfranco di Sotto 2
Cosenza 2
Dearborn 2
Esslingen am Neckar 2
Lanzhou 2
Lappeenranta 2
Lausanne 2
Legnaro 2
Marcon 2
Marostica 2
Montefelcino 2
Parma 2
Pune 2
Rockville 2
Rome 2
San Giorgio Della Richinvelda 2
San Jose 2
Sofia 2
Tokyo 2
Valsamoggia 2
Albany 1
Bolzano 1
Brussels 1
Cairns 1
Carmichael 1
Castel Maggiore 1
Chengdu 1
Chicago 1
Chongqing 1
Geislingen an der Steige 1
Totale 4.927
Nome #
Heme oxygenase-1 is an important modulator in limiting glucose-induced apoptosis in human umbilical vein endothelial cells 153
STAT3 mutation impacts biological and clinical features of T-LGL leukemia 149
Searching for an additional treatment to slowing the progression of Fabry disease 139
p66Shc deletion or deficiency protects from obesity but not metabolic dysfunction in mice and humans 137
Oxidative stress - chronic kidney disease - cardiovascular disease: A vicious circle 132
Proinflammatory/profibrotic effects of aldosterone in Gitelman’s syndrome, a human model opposite to hypertension 127
Integrated CLL Scoring System, a New and Simple Index to Predict Time to Treatment and Overall Survival in Patients With Chronic Lymphocytic Leukemia 126
Co-stimulatory modulation in rheumatoid arthritis: The role of (CTLA4-Ig) abatacept 121
Diabetes induces p66(shc) gene expression in human peripheral blood mononuclear cells: Relationship to oxidative stress 120
Metformin improves putative longevity effectors in peripheral mononuclear cells from subjects with prediabetes. A randomized controlled trial. 116
Oxidative Stress and Cardiovascular-Renal Damage in Fabry Disease: Is There Room for a Pathophysiological Involvement? 115
Prognostic and Predictive Effect of IGHV Mutational Status and Load in Chronic Lymphocytic Leukemia: Focus on FCR and BR Treatments 114
Absence of vascular remodelling in a high angiotensin-II state (Bartter's and Gitelman's syndromes): implications for angiotensin II signalling pathways 112
Is heme oxygenase-1 turning out to be a key positive regulator for oxidative stress? 111
Effect of canrenone and amiloride on the prooxidative effect induced by aldosterone in human mononuclear leukocytes in vitro. 109
The Redox Enzyme p66Shc Contributes to Diabetes and Ischemia-Induced Delay in Cutaneous Wound Healing 101
Comment on “Vitamin E supplementation improves high-density lipoprotein and endothelial functions in end-stage kidney disease patients undergoing hemodialysis” by Mune et al. Clinical Nephrology DOI 10.5414/CN109197 e-pub: April 9, 2018 101
Effect of olmesartan medoxomil on number and survival of circulating endothelial progenitor cells and calcitonin gene related peptide in hypertensive patients. 100
Rosiglitazone reduces glucose-induced oxidative stress mediated by NAD(P)H oxidase via AMPK-dependent mechanism. 98
Gender differences in endothelial progenitor cells and cardiovascular risk profile: the role of female estrogens. 98
At the crossroads of longevity and metabolism: The metabolic syndrome and lifespan determinant pathways 94
Gαq/p63RhoGEF interaction in RhoA/Rho kinase signaling: investigation in Gitelman’s syndrome and implications with hypertension 94
Oxidative stress and post-transplant hypertension in pediatric kidney-transplanted patients 94
Abnormalities of Gq-mediated cell signaling in Bartter's and Gitelman's syndome 92
Myeloid calcifying cells promote atherosclerotic calcification via paracrine activity and allograft inflammatory factor-1 overexpression 90
Oxidative stress and the altered reaction to it in Fabry disease: A possible target for cardiovascular-renal remodeling? 90
Specific effect of arachidonic acid on inducible nitric oxide synthase mRNA expression in human osteoblastic cells 89
Increased level of p63RhoGEF and RhoA/Rho kinase activity in hypertensive patients 89
Reduced expression of regulator of G-protein signaling 2 (RGS2) in hypertensive patients increases calcium mobilization and ERK1/2 phosphorylation induced by angiotensin II 87
Endothelial dysfunction in type 2 diabetes mellitus. 87
Effect of aldosterone and glycyrrhetinic acid on the protein expression of PAI-1 and p22(phox) in human mononuclear leukocytes 86
Oxidative stress and profibrotic action of aldosterone 85
Analysis of Gq protein alpha subunit mRNA expression in human monocytes: relevance of the purification step 82
Increased expression of regulator of G protein signaling-2 (RGS-2) in Bartter's/Gitelman's syndrome. A role in the control of vascular tone and implication for hypertension 80
P1190 Oxidative stress and inflammation in peritoneal dialysis: dangerous and to be solved. 79
Specific effect of arachidonic acid on inducible nitric oxide synthase mRNA expression in human osteoblastic cells 78
Assessing the Relationship of Angiotensin II Type 1 Receptors with Erythropoietin in a Human Model of Endogenous Angiotensin II Type 1 Receptor Antagonism. 78
Gitelman's Syndrome: characterization of a novel c.1181G>A point mutation and functional classification of the known mutations. 78
Monocyte NADPH oxidase subunit p22(phox) and inducible hemeoxygenase-1 gene expressions are increased in type II diabetic patients: Relationship with oxidative stress 77
Rho/Rho-kinase and C-reactive protein relationship in hypertension and atherosclerosis 75
Effects of androgens on endothelial progenitor cells in vitro and in vivo 75
The search for a link between inflammation and hypertension - contribution from Bartter's/Gitelman's syndromes 72
Early markers of inflammation in a high angiotensin II state - results of studies in Bartter's/Gitelman's syndromes 71
Silencing regulator of G protein signaling-2 (RGS-2) increases angiotensin II signaling: insights into hypertension from findings in Bartter's/Gitelman's syndromes 71
Uric acid and cardiovascular-renal disease risk. Insights from a human model opposite to hypertension 71
Rho Kinase Activity, Connexin 40, and Atrial Fibrillation: Mechanistic Insights from End-Stage Renal Disease on Dialysis Patients 71
Effect of doxazosin on oxidative stress related proteins in essential hypertensive patients 70
Antioxidant effect of L-carnitine and its short chain esters - Relevance for the protection from oxidative stress related cardiovascular damage 69
Oxidative stress-related factors in Bartter's and Gitelman's syndromes: relevance for angiotensin II signalling 69
Hemodiafiltration With Online Regeneration of Ultrafiltrate: Effect on Heme-Oxygenase-1 and Inducible Subunit of Nitric Oxide Synthase and Implication for Oxidative Stress and Inflammation 68
Cardiac dysfunction in Bartter's and Gitelman's syndromes 67
Bartter's and Gitelman's syndromes: a confirm in humans of the utility of Rho kinase inhibition for cardiovascular protection. 65
Rho kinase inhibition and vascular protection: support from studies in Bartter and Gitelman syndrome. 61
Endothelial progenitor cells relationships with clinical and biochemical factors in a human model of blunted angiotensin II signaling 59
NADPH oxidase, superoxide overproduction and nitric oxide bioavailability in essential hypertension 58
Insulin signaling, glucose metabolism, and the angiotensin II signaling system - Studies in Bartter's Gitelman's syndromes 57
Targeting of HSP70/HSF1 Axis Abrogates In Vitro Ibrutinib-Resistance in Chronic Lymphocytic Leukemia 57
Oxidative stress in kidney transplant patients with calcineurin inhibitor-induced hypertension: effect of ramipril 53
Reduced mRNA and protein content of rho guanine nucleotide exchange factor (RhoGEF) in Bartter's and Gitelman's syndromes: relevance for the pathophysiology of hypertension. 52
Effect of manidipine on gene expression and protein level of oxidative stress-related proteins: p22(phox) and HO-1 - Relevance for antihypertensive and anti-remodeling effects 51
Tracing Angiotensin II's Yin -Yang effects on cardiovascular-renal pathophysiology. Yin and yang systems of Ang II. 50
PLC beta 1-SHP-2 complex, PLC beta 1 tyrosine dephosphorylation and SHP-2 phosphatase activity: a new part of Angiotensin II signaling? 48
Effect of epoetin on oxidative stress in hemodialysis. A molecular biologic approach 41
Kidney transplant in Gitelman's syndrome. Report of the first case. 41
Arterial hypertension and oxidative stress induced by cyclosporin. Effect of carvedilol 40
Oxidative stress-related proteins in a Conn's adenoma tissue. Relevance for aldosterone's prooxidative and proinflammatory activity. 39
Oxidative stress and nitric oxide system in post-transplant hypertension 38
Angiotensin II long-term signaling in Bartter's/Gitelman's syndrome. Relevance for hypertension and cardiovascular remodeling 38
Rho kinase and PAI-1 in Bartter/Gitelman syndromes. Relationship to angiotensin II signaling 36
Rho kinase activity and atrial fibrillation: insights fromchronic kidney disease and dialysis patients. 35
L'effetto ipotensivo del carvedilolo nell'ipertensione del post-trapianto si associa a riduzione dello stress ossidativo e della fibrogenesi. Ruolo di NO, O2- e TGFbeta 30
Oxidative stress and TGFbeta in kidney-transplanted patients with cyclosporin-induced hypertension. Effect of carvedilol and nifedipine 29
Role of insulin-like growth factor-1 in primary osteoporosis: a correlative study 23
Focal adhesion kinase activation by calcium-dependent calpain is involved in chronic lymphocytic leukaemia cell aggressiveness 20
The added value of karyotype in predicting the need for therapy in chronic lymphocytic leukemia with 13q deletion 16
Chronic Lymphocytic Leukemia (CLL) with Borderline Immunoglobulin Heavy Chain Mutational Status, a Rare Subgroup of CLL with Variable Disease Course 9
Intra-articular etanercept treatment for severe diffuse pigmented villonodular knee synovitis 8
Totale 5.911
Categoria #
all - tutte 21.962
article - articoli 21.408
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.370


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.135 0 0 0 191 138 101 144 158 155 107 85 56
2020/2021935 46 65 27 78 41 85 42 84 131 138 91 107
2021/20221.031 17 124 128 84 45 67 63 118 43 17 115 210
2022/2023783 151 96 22 127 111 89 0 54 84 9 30 10
2023/2024399 25 58 35 37 33 52 26 11 16 28 37 41
2024/2025223 4 103 66 50 0 0 0 0 0 0 0 0
Totale 5.911